Clinical Trial Update: Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of capecitabine, oxaliplatin, and bevacizumab in metastatic or recurrent colorectal cancer; results were posted after s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Herbert Hurwitz, MD | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-03-14